Enfusion Stock Return On Asset
| ENFNDelisted Stock | USD 10.76 0.00 0.00% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Enfusion's long-term financial health and intrinsic value.
Enfusion |
Enfusion Company Return On Asset Analysis
Enfusion's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Enfusion Return On Asset | 0.0305 |
Most of Enfusion's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Enfusion is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Enfusion has a Return On Asset of 0.0305. This is 101.06% lower than that of the Software sector and significantly higher than that of the Information Technology industry. The return on asset for all United States stocks is 121.79% lower than that of the firm.
Enfusion Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Enfusion's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Enfusion could also be used in its relative valuation, which is a method of valuing Enfusion by comparing valuation metrics of similar companies.Enfusion is currently under evaluation in return on asset category among its peers.
Enfusion Fundamentals
| Return On Equity | 0.0442 | ||||
| Return On Asset | 0.0305 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 1.01 B | ||||
| Shares Outstanding | 94.8 M | ||||
| Shares Owned By Insiders | 4.73 % | ||||
| Shares Owned By Institutions | 96.25 % | ||||
| Number Of Shares Shorted | 1.3 M | ||||
| Price To Earning | 0.11 X | ||||
| Price To Book | 13.93 X | ||||
| Price To Sales | 5.06 X | ||||
| Revenue | 201.61 M | ||||
| Gross Profit | 136.74 M | ||||
| EBITDA | 6.16 M | ||||
| Net Income | 3.92 M | ||||
| Cash And Equivalents | 56.56 M | ||||
| Cash Per Share | 0.84 X | ||||
| Total Debt | 20.31 M | ||||
| Current Ratio | 9.17 X | ||||
| Book Value Per Share | 0.77 X | ||||
| Cash Flow From Operations | 34.68 M | ||||
| Short Ratio | 1.46 X | ||||
| Earnings Per Share | 0.03 X | ||||
| Price To Earnings To Growth | 2.35 X | ||||
| Target Price | 11.25 | ||||
| Number Of Employees | 1.14 K | ||||
| Beta | 0.93 | ||||
| Market Capitalization | 1.02 B | ||||
| Total Asset | 143.26 M | ||||
| Retained Earnings | (170.11 M) | ||||
| Working Capital | 66.19 M | ||||
| Net Asset | 143.26 M |
About Enfusion Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Enfusion's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Enfusion using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Enfusion based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in Enfusion Stock
If you are still planning to invest in Enfusion check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Enfusion's history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |